Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-06-15 @ 7:59 PM
Study NCT ID:
NCT03727750
Status:
COMPLETED
Last Update Posted:
2022-03-25
First Post:
2018-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML
Sponsor:
Organization: